... II Informatix dimensioning ... optional module that ... analysis, multidimensional scaling, ... MANOVA, and self-organizing ...
... Cell Lines ,High Quality, Functionally-Validated, Ion Channel ... known for having a critical role in ... a key function in pain, CNS and ... have been investigated in therapeutic areas, such ...
... gel marker mix was designed specifically to aid ... contains a complement of seven reduced and denatured ... those who use markers to assess 2-D system ... of proteins undergoing 2-D separation and analysis. , ...
... consist of seven reduced, denatured proteins (equine ... rabbit muscle GAPDH, bovine muscle actin, BSA, ... ranging from 4.5 to 8.5 and molecular ... 2-D standards provide calibrated references for the ...
Biology Products:(Date:12/14/2009)... use as a defining feature of humans. That,s until examples ... birds and an array of other mammals. Now, a report ... a Cell Press publication, adds an octopus to the growing ... manages a behavioral trick that the researchers call stilt walking. ... coconut shell "bowls," makes its eight arms rigid, and raises ...
(Date:12/13/2009)... about how a popular class of drugs used ... previously hidden components of chemical communication in the ... the illness, people with schizophrenia also struggle to ... order, difficulties that interfere with their ability to ... Schroeder, a student in the medical scientist training ...
(Date:12/11/2009)... consumer demand for premium fruit increases, growers are ... market. And to boost their bottom line, orchard ... increase fruit quality while reducing labor costs. , ... to produce larger, healthier fruit, is among the ... impact on fruit production overhead, and, ultimately, prices ...
Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Horizontal string trimmer reduces labor costs, increases peach size 2WAV Distribution Partners with Vecima Networks Inc 60866 1WAV Distribution Partners with Vecima Networks Inc 60866 2WAV Distribution Partners with Vecima Networks Inc 60866 3Father Norman Weslin and Four Pro Lifers Still in Jail 60863 1Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 60860 1Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 60860 2Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 60860 3(Date:12/16/2009)... Special Protocol Assessment with the Food and ... /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... global biopharmaceutical company focused on oncology and ... its partner Keryx Biopharmaceuticals Inc. ("Keryx") ( ... trial for perifosine (KRX-0401), the Company,s PI3K/Akt ...
(Date:12/15/2009)... Calif., Dec. 15 Epeius Biotechnologies Corporation, ... genetic medicine, gained international validation of the cutting-edge ... , when scientists around the world rediscovered the ... major locus of cancer pathogenesis and disease progression, ... Recently, scientists at the NIH National Cancer Institute ...
(Date:12/15/2009)... Medical, Inc. (OTC Bulletin Board : AEMD) announced ... Comper have joined the Science Advisory ... Schorey and Dr. Comper are leading researchers in ... of Aethlon Medical, was recently formed to leverage ... being advanced as an adjunct therapy for Hepatitis-C ...
(Date:12/15/2009)... The Center for Business Intelligence (CBI), a ... announce the full agenda for the ... . The forum will take place at ... ,, Over 1,500 senior-level Finance, Accounting, Audit ... event since its inception, and this year,s ...
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Biology NavigationMedical Navigation